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Objectives: To determine the peak velocity ratio (PVR) threshold at which to intervene and correct duplex detected vein 
graft stenoses. 
Design. Prospective study. 
Materials: Infrainguinal vein grafts in patients attending the vascular studies for routine postoperative surveillance. 
Methods: Colour duplex detected stenotic vein graft lesions with a peak velocity ratio (PVR) between 2.0 and 2.9 were 
identified and monitored by serial duplex scans performed monthly for 3 months and then at 3-monthly intervals thereafter. 
At the end of the study period, the outcome of these lesions were analysed. 
Results: Thirty-eight lesions were identified from 32 grafts. Of these lesions, sixteen (42%) resolved, 11 (29%) remained 
stable and 11 (29%) progressed to a PVR of >_3.0 and underwent angioplasty. There were no occlusions in any of the 
grafts during the period of study. 
Conclusion: Colour duplex detected vein graft stenoses with a PVR of less than 3.0 can be treated expectantly if grafts 
with stenoses with a PVR 2.0-2.9 are scanned every month for at least 3 months after detection. 
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Introduction Patients and Methods 
Postoperative infrainguinal vein graft surveillance 
using colour duplex is widely practised. 1-4 Over the 
years, several parameters have been derived from 
duplex examinations to estimate the degree of stenosis. 
Jfiger et al. 5 first demonstrated that the relative increase 
of velocity across a stenosis could be used as an 
indicator of disease severity in native vessels, and 
since then the peak velocity ratio (PVR) has been used 
to grade stenoses that develop in vein grafts. 6-s The 
threshold value for correction of detected lesions varies 
from one centre to another. A PVR of 2.0 corresponds 
approximately with a 50% or more reduction in vessel 
diameter and many centres, 9-12 including our own, 
intervene at this point in order to prevent subsequent 
occlusion. However, other authors have suggested that 
intervention is necessary only for those lesions with a 
PVR above 3.013 or 3.5.14 The aim of the present study 
was to determine whether the threshold for inter- 
vention could be safely raised from a PVR of 2.0 to 
3.0 without increasing the risk of graft thrombosis. 
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A prospective study was commenced recruiting from 
patients attending the vascular studies unit of the 
Leicester Royal Infirmary for infrainguinal vein graft 
surveillance. The protocol for postoperative infra- 
inguinal vein graft surveillance in this centre is a colour 
duplex examination ofthe graft and its anastomoses at 
1, 3, 6, 9, and 12 months after surgery. Thereafter the 
patients are scanned at 6-monthly intervals. The scans 
are performed by experienced vascular technicians 
using one of two colour duplex scanners (Diasonics 
Masters, Diasonics sonotron, Bedford U.K. and ATL 
Ultramark 9 HDI, ATL Letchworth U.K.) at probe 
frequencies of either 5MHz or 10MHz. Detected sten- 
oses are graded according to the calculated PVR. This 
is determined as the ratio of the peak velocity within 
the stenosis and the peak velocity of the adjacent 
segment of normal graft. Grafts were considered oc- 
cluded if there was no colour on the duplex scan and 
no pulsatile flow on the pulsed Doppler. 
Prior to the start of this study the PVR threshold 
for intervention was > 2.0. However, starting in Aug- 
ust 1995 this threshold was raised to >3.0. For the 
purposes of this study, grafts that developed a primary 
stenosis with a PVR of 2.0-2.9 were scanned every 
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month. If the stenosis progressed to a PVR of >3.0 
the stenosis was corrected by angioplasty; if,however, 
the stenosis regressed or remained stable for 3 months 
the graft returned to the routine surveillance protocol. 
A primary lesion was defined as one that was detected 
in an area of a graft hat had no previous abnormalities 
or endovascular intervention. At the end of the study 
the data relating to the outcome of these stenoses was 
analysed. 
Results 
Two-hundred and ten vein grafts underwent post- 
operative surveillance between August 1995 and April 
1997. During this period 12 stenoses in 11 grafts were 
detected with an initial PVR >3.0 and were im- 
mediately treated by angioplasty. A further 32 grafts 
developed 38 primary stenotic lesions with a PVR 
between 2.0 and 2.9. 
Seventeen of the 32 grafts were in situ, 13 were 
reversed and two were composite. Twelve grafts were 
above-knee, 20 were below-knee. Thirty-two stenoses 
were located within the graft and six were at an 
anastomosis. Of the 38 stenoses with a PVR between 
2.0 and 2.9, 16 (42%) regressed spontaneously, 11 (29%) 
remained stable and 11 (29%) progressed to a PVR of 
>3.0 and underwent angioplasty. No grafts with a 
PVR between 2.0 and 2.9 occluded whilst they were 
being 'observed'. 
The median (range) time taken to develop astenosis 
with a PVR of 2.0-2.9 was 12 (1-100) weeks after 
surgery. The time of onset of stenoses that progressed 
(n = 11) was 8 (2-100) weeks compared to 18 (1-100) 
weeks for those that did not (n = 27). This trend was 
not statistically significant (P=0.46, Mann-Whitney 
U-Test). Stenoses that did progress did so at a median 
(range) time of 6 (4-36) weeks from the time at which 
they were detected. 
Discussion 
There are several duplex derived parameters that can 
be used to grade the severity of a stenosis. These 
include the peak mean velocity, the peak systolic ve- 
locity index, the end-diastolic velocity and the peak 
velocity ratio. 13'15'16'17 In the present study we have used 
the PVR as the sole parameter tograde detected lesions 
because it has previously been shown to be highly 
sensitive for detecting lesions within vein grafts. 11 
Many authors tend to repair all lesions with a PVR of 
2.0 which corresponds approximately to a diameter 
reduction of 50%. One of the strongest arguments 
supporting the use of a PVR of 2.0 or more as a criteria 
to correct graft stenoses i evident in the study reported 
by Mattos et al. 9 In their study of 110 vein graft stenoses, 
33 grafts harbouring lesions with a PVR of 2.0 or above 
were not corrected. The 3-year patency rate in these 
grafts was 57%. This was significantly worse than the 
3-year patency of 83% achieved by correcting lesions 
with a PVR of 2.0 or more in 24 other grafts. Thus 
they concluded that lesions with a PVR of 2.0 were at 
a significantly increased risk of occlusion and that 
correction at this stage would significantly improve 
patency rates. There have been other studies sup- 
porting these findings.4 '16"18 The problem with these 
studies, however, is that they have not attempted 
to determine the natural history of these lesions by 
observing them until they developed a higher PVR 
before they were corrected. 
In contrast, we have found that it is safe to observe 
stenoses that develop in vein grafts if the PVR is 
between 2 and 2.9. Interestingly, other authors have 
recently come to similar conclusions. Thus, Idu et al. 
recently presented their findings in a similar pro- 
spective study (Idu et al. - unpublished observations). 19 
In their study, analysis of data from 300 patients 
showed that the PVR provided the best correlation 
with angiographic detected stenoses and that a thresh- 
old level of > 3.0 was the optimal threshold for pre- 
dicting grafts that would require revision. Caps et al. s 
using a cut off PVR of 3.5 reported no graft hromboses 
in lesions with a PVR of 2.5 or less. However, they 
experienced three thromboses in those grafts with a 
PVR between 2.5 and 3.5. This may be because of the 
slightly higher cut-off point that they used. Fur- 
thermore, those three grafts were associated with a 
significant reduction in the ankle brachial index (ABI) 
or return of symptoms. 
Bandyk 14 suggested that asymptomatic lesions with 
a normal flow velocity and an ankle brachial index 
of more than 0.9 should attain a PVR of 3.5 before 
correction. Westerband et al. have recently completed 
a prospective study on 101 vein grafts designed to 
validate a threshold PVR of 3.5 as the criteria for 
intervention. In that study, of 43 grafts with stenosis 
(PVR >1.5), 20 (46%) remained stable or spon- 
taneously regressed and the remaining 23 (54%) pro- 
gressed. However, out of the 23 lesions that progressed, 
three occluded before intervention. 2° The occurrence of
three occlusions in that study suggests that a threshold 
PVR of 3.5 may be too high and a PVR of 3.0 may be 
more appropriate. 
Part of the problem in graft surveillance and duplex 
scanning is the paucity of knowledge on the natural 
history of detected stenoses. There is a tendency to 
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apply the same criteria used in native vessels to vein 
grafts. I1However, the underlying cause of stenosis is 
different. The arteriosclerosis een in the native vessels 
tends to be progressive whilst intimal hyperplasia has 
been known to spontaneously resolve. 21 This fact is 
supported by our results and there seems to be a 
consistent pattern emerging from the few studies on 
the natural history of vein graft stenosis. We found 
that most lesions that progress do so within a relatively 
short period of time (median time of 6 weeks) which 
is consistent with findings from other studies, '21 
This study has shown that if vein graft stenoses 
with a PVR of 2.0-2.9 remain stable during the course 
of 3 months, stenosis with a PVR <3.0 can be treated 
expectantly. We therefore conclude that with this pro- 
tocol the threshold PVR for correcting duplex detected 
graft stenosis hould be > 3.0. This policy will mark- 
edly reduce the number of interventions without im- 
pairing graft patency. 
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